Sort by
Refine Your Search
-
of Biological Safety risk assessments and Biological Safety audit and inspections. The post holder will lead on the safety of Home Office designated facilities within the faculty, including inspection and
-
of visionary leadership, coupled with a passion for delivering exceptional customer service and driving operational excellence. They will lead a sizable team in Facilities Management, inspiring them
-
change. This is an exciting opportunity for candidates looking to lead on process improvement and innovation in a large and busy department, and who wish to utilise their skills and expertise in research
-
transfer partnerships, consultancy services, intellectual property management, clinical trials management, audit, and compliance. About the role: A unique opportunity to lead and be an integral part of
-
hyperactivity and addictions), and cognitive disorders (learning disabilities and the autistic spectrum). Scientists at the SGDP lead some of the UK’s foremost longitudinal cohort and twin studies including TEDS
-
and PET scanning) to approximately 15,000 patients a year at Guy’s and St Thomas’ NHS Foundation Trust (GSTT). In partnership with GSTT’s Clinical Imaging & Medical Physics (CLIMP) Directorate
-
, Mathematical & Engineering Sciences (NMES) is a vibrant faculty based in the heart of London with a long tradition of world-leading research and teaching in physics, mathematics, chemistry, informatics and
-
. Department: Engineering. Contact details:Barbara Shollock. [email protected] Location: Strand Campus. Category: Academic & Teaching. About us We are a vibrant, diverse Department that looks to lead
-
enabled us to raise substantial funds to help tackle some of the world’s biggest challenges. Ambitious and innovative, the team has won awards such as a CASE Platinum Award for Fundraising and a CASE Gold
-
molecular basis for DQ6-conferred susceptibility could lead to novel disease prevention strategies including refinements to antigen-specific immunotherapy approaches or adoptive Treg cell therapies